PAVmed Inc., a multi-product, commercial-stage medical technology company based in New York City, operates in Medical Devices, Diagnostics, and Digital Health, and went public in 2016. Key subsidiaries include Lucid Diagnostics for cancer prevention diagnostics, marketing EsoGuard and EsoCheck, and Veris Health, which focuses on personalized cancer care through remote monitoring technologies.
PAVmed (PAVM) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, PAVmed's actual EPS was -$1.19, beating the estimate of -$1.48 per share, resulting in a 19.72% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
